As cybersecurity threats have proliferated across industries in recent years, biopharma companies have emerged as prominent targets, with intellectual property, patient data and other sensitive ...

Novo Nordisk NOVO.B0.86%increase; up pointing triangle said prescriptions for its Wegovy weight-loss pill have surpassed three million since launching in early January. The Danish drugmaker said late ...

Clinical and regulatory wins are important catalysts for pharmaceutical companies. In fact, these often drive the stock price just as much as financial results. The market rewarded Novo Nordisk for ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

Google is using on-device AI to analyze how you use your Android phone and provide “Contextual suggestions.” Once available, scroll down to the bottom of Settings > [your name] > All services. There ...

Novo Nordisk is working with OpenAI on a broad deal that will use artificial intelligence to more quickly develop new medications as well as help train its workforce. Novo Nordisk’s U.S.-listed shares ...

Novo Nordisk A/S is doubling down on obesity and diabetes, putting it at loggerheads with investors calling for the Danish drugmaker to diversify after it lost ground to rivals in the competitive ...

Novo Nordisk said Tuesday it will slash its prices for Wegovy and Ozempic beginning next year by up to 50%, highlighting the growing competition among pharmaceutical firms for customers seeking weight ...

Novo Nordisk will slash U.S. list prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 50% starting next year, the Danish drugmaker said on Tuesday. Limited time: Save ...

Novo Nordisk’s experimental weekly shot CagriSema was shown to lead to less dramatic weight loss compared to rival Lilly’s Tirzepatide, the drug behind Zepbound and Mounjaro, in an 84-week trial, Novo ...

Novo's shares, which are near their lowest since Wegovy was introduced in June 2021, were 5.4% higher at 1341 GMT. Late on Thursday, FDA Commissioner Marty Makary said on X that the agency would "take ...

Feb 4 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Wednesday it will launch some doses of its oral semaglutide for diabetes under the brand name Ozempic pill in the second quarter of ...